Oxycodone DETERx, an extended-release, abuse-deterrent formulation for management of patients with chronic pain and chronic pain with dysphagia

被引:2
|
作者
Kopecky, E. [1 ]
Fleming, A. [1 ]
Findlen, K. [1 ]
Mayock, S. [1 ]
Varanasi, R. [1 ]
Saim, S. [1 ]
机构
[1] Coll Pharmaceu Inc, Canton, MA USA
来源
JOURNAL OF PAIN | 2014年 / 15卷 / 04期
关键词
D O I
10.1016/j.jpain.2014.01.370
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
459
引用
收藏
页码:S90 / S90
页数:1
相关论文
共 50 条
  • [31] A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone
    Webster, Lynn R.
    Kopecky, Ernest A.
    Smith, Michael D.
    Fleming, Alison B.
    PAIN MEDICINE, 2016, 17 (06) : 1112 - 1130
  • [32] Analgesic efficacy, safety, and tolerability of a long- acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate- release oxycodone
    Markman, John
    Meske, Diana S.
    Kopecky, Ernest A.
    Vaughn, Ben
    O'Connor, Melinda L.
    Passik, Steven D.
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 2051 - 2059
  • [33] Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study
    Webster, Lynn R.
    Kinzler, Eric R.
    Pantaleon, Carmela
    Iverson, Matthew
    Aigner, Stefan
    ADVANCES IN THERAPY, 2019, 36 (07) : 1730 - 1740
  • [34] Extraction testing of a novel extended-release, abuse-deterrent formulation of morphine, Morphine ARER, in common household solvents
    Bianchi, R.
    Kinzler, E.
    DiFalco, R.
    Shah, M.
    Aigner, S.
    JOURNAL OF PAIN, 2014, 15 (04): : S77 - S77
  • [35] Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study
    Lynn R. Webster
    Eric R. Kinzler
    Carmela Pantaleon
    Matthew Iverson
    Stefan Aigner
    Advances in Therapy, 2019, 36 : 1730 - 1740
  • [36] Extended-release formulations of tramadol in the treatment of chronic pain
    Pergolizzi, Joseph V., Jr.
    Taylor, Robert, Jr.
    Raffa, Robert B.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (11) : 1757 - 1768
  • [37] Profile of extended-release oxycodone/acetaminophen for acute pain
    Bekhit, Mary Hanna
    JOURNAL OF PAIN RESEARCH, 2015, 8 : 719 - 728
  • [38] Managing severe pain and abuse potential: the potential impact of a new abusedeterrent formulation oxycodone/naltrexone extended-release product
    Pergolizzi, Joseph V., Jr.
    Taylor, Robert, Jr.
    LeQuang, Jo Ann
    Raffa, Robert B.
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 301 - 311
  • [39] Current and future development of extended-release, abuse-deterrent opioid formulations in the United States
    Webster, Lynn R.
    Markman, John
    Cone, Edward J.
    Niebler, Gwendolyn
    POSTGRADUATE MEDICINE, 2017, 129 (01) : 102 - 110
  • [40] Dissolution studies in the presence of alcohol with an abuse-deterrent, extended-release morphine product candidate
    Elhauge, T.
    Kristensen, L.
    Dayno, J.
    Lindhardt, K.
    JOURNAL OF PAIN, 2016, 17 (04): : S80 - S81